Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV. Mathur P, Ramadhani HO, Kaplan R, Stafford KA, et al. AIDS 2024;38:1437-1439.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mathur P, Ramadhani HO, Kaplan R, Stafford KA, et al. Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV. AIDS 2024;38:1437-1439.
PMID: 38932748